Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients
- 1 August 2009
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 38 (3), 233-240
- https://doi.org/10.1152/physiolgenomics.90364.2008
Abstract
The present study was aimed at identifying chronic heart failure (CHF) biomarkers from peripheral blood mononuclear cells (PBMCs) in patients with ischemic (ICM) and nonischemic dilated (NIDCM) cardiomyopathy. PBMC gene expression profiling was performed by Affymetrix in two patient groups, 1) ICM ( n = 12) and 2) NIDCM ( n = 12) New York Heart Association (NYHA) III/IV CHF patients, vs. 3) age- and sex-matched control subjects ( n = 12). Extracted RNAs were then pooled and hybridized to a total of 11 microarrays. Gene ontology (GO) analysis separated gene profiling into functional classes. Prediction analysis of microarrays (PAM) and significance analysis of microarrays (SAM) were utilized in order to identify a molecular signature. Candidate markers were validated by quantitative real-time polymerase chain reaction. We identified a gene expression profiling that distinguished between CHF patients and control subjects. Interestingly, among the set of genes constituting the signature, chemokine receptor (CCR2, CX3CR1) and early growth response (EGR1, 2, 3) family members were found to be upregulated in CHF patients vs. control subjects and to be part of a gene network. Such findings were strengthened by the analysis of an additional 26 CHF patients ( n = 14 ICM and n = 12 NIDCM), which yielded similar results. The present study represents the first large-scale gene expression analysis of CHF patient PBMCs that identified a molecular signature of CHF and putative biomarkers of CHF, i.e., chemokine receptor and EGR family members. Furthermore, EGR1 expression levels can discriminate between ICM and NIDCM CHF patients.Keywords
This publication has 40 references indexed in Scilit:
- Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failureJournal of Molecular and Cellular Cardiology, 2008
- Role of rat ? adducin in angiogenesis: Null effect of the F316Y polymorphismCardiovascular Research, 2007
- The Failing Heart — An Engine Out of FuelNew England Journal of Medicine, 2007
- Early Growth Response-1 in Cardiovascular PathobiologyCirculation Research, 2006
- Immune Activation in Chronic Heart FailureThe American Journal of Cardiology, 2005
- The prognostic value of N-terminal proB-type natriuretic peptideNature Clinical Practice Cardiovascular Medicine, 2005
- Sustained β 1 -Adrenergic Stimulation Modulates Cardiac Contractility by Ca 2+ /Calmodulin Kinase Signaling PathwayCirculation Research, 2004
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003
- Reciprocal Regulation of β1-Adrenergic Receptor Gene Transcription by Sp1 and Early Growth Response Gene 1: Induction of EGR-1 Inhibits the Expression of the β1-Adrenergic Receptor GenePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001